ArticleAdvances in therapy2021

Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population.

Chongqing Tan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.